Today 9:08 AM
Global Legal Chronicle
Biond is a pharmaceutical company that researches and develops immuno-therapies for oncology and autoimmune diseases. Read more
Biond is a pharmaceutical company that researches and develops immuno-therapies for oncology and autoimmune diseases. Read more
Co-Founder & CEO
Tehila Ben Moshe
Genelux is the biggest rival of Biond Biologics. Genelux is headquartered in San Diego, California, and was founded in 2001. Like Biond Biologics, Genelux also operates in the Biotechnology space. Genelux generates 234% the revenue of Biond Biologics.
Today 9:08 AM
Global Legal Chronicle
January 25, 2021
BioSpace
No recent acquisitions found related to Biond Biologics
Since Biond Biologics was founded in 2016, it has participated in 1 round of funding. In total Biond Biologics has raised $17.0M. Biond Biologics' funding round was on Jan 2019 for a total of $17.0M
No recent investments found related to Biond Biologics